Search

Your search keyword '"Camoin, Luc"' showing total 248 results

Search Constraints

Start Over You searched for: Author "Camoin, Luc" Remove constraint Author: "Camoin, Luc" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
248 results on '"Camoin, Luc"'

Search Results

2. Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression

9. Tetraspanin-6 negatively regulates exosome production

10. Downregulation of stromal syntenin sustains AML development

12. Exploring dimethylsulfate for in vivo proteome footprinting

16. Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers

19. Mapping the SLP76 interactome in T cells lacking each of the GRB2-family adaptors reveals molecular plasticity of the TCR signaling pathway

20. Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

21. Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis

26. UFMylation of MRE11 is essential for telomere length maintenance and hematopoietic stem cell survival

27. Insights into animal septins using recombinant human septin octamers with distinct SEPT9 isoforms

29. ARHGAP45 controls naïve T‐ and B‐cell entry into lymph nodes and T‐cell progenitor thymus seeding

30. A systems biology approach reveals neuronal and muscle developmental defects after chronic exposure to ionising radiation in zebrafish

33. ZZW-115–dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents

38. Additional file 2. of Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation

39. Additional file 1. of Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation

41. Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer

43. Additional file 3: of Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

44. Additional file 1: of Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

45. Additional file 4: of Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

46. Additional file 2: of Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

47. Identification of O-Glcnacylated Proteins in Trypanosoma cruzi

48. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis

49. Regulation of NUB1 Activity through Non- Proteolytic Mdm2-Mediated Ubiquitination

50. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo

Catalog

Books, media, physical & digital resources